Trophoblasts, collected from the mother during a blood draw, can determine fetal genetic abnormalities currently diagnosed through amniocentesis or chorionic villi sampling.

Sequences from dozens of ancient remains from Siberia reveal the closest ancient relative of Native Americans found outside of North America.

A trial called BabySeq, in which researchers performed genomic sequencing on 159 newborns, identified children susceptible to diseases that regular screening doesn’t look for.

Nebula Genomics is among the first blockchain-based companies to reward users for contributing personal data for research.

Luna DNA, Nebula Genomics, and other “bio-brokers” will allow customers to make money by granting access to their genetic and personal information for research purposes.

Researchers at the Rare Genomics Institute look at how families finance the cost of diagnostic exome sequencing.

Two large-scale studies reveal new insights into the genomic characteristics of childhood cancers.

A handful of infants in a neonatal intensive care unit who were diagnosed with rare diseases using whole-genome sequencing had shorter hospital stays and better health outcomes, researchers find.

The first randomized trial to examine whole-genome sequencing in healthy people uncovers disease-causing genetic variants, but the overall benefits to this population are ambiguous.